BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

SuperNova Diagnostics to Present at Biotech Showcase(TM) 2012 During JP Morgan Healthcare Conference January 9 - 12


1/3/2012 10:43:40 AM

WASHINGTON, LONDON and HONG KONG, Jan. 3, 2012 /PRNewswire/ -- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, announced that Neil J. Campbell, President and CEO, will present a corporate and technology overview at Biotech Showcase 2012 in San Francisco, CA. Mr. Campbell's presentation is scheduled for Monday, January 9, 2012 at 4:45pm in the Stockton Room at the Parc 55 Wyndham Union Square Hotel.

The presentation will include an overview of SuperNova's proprietary point-of-care (POC) and point-of-use (POU) diagnostic technology, targeted for four industry sectors: human health, animal health, industrial and biodefense / biosecurity; as well as provide additional details on the company's recent commercial partnership with Concile, GmbH.

"Biotech Showcase is the premier event for investors and business leaders in the healthcare industry, and is an ideal opportunity for SuperNova to feature its 'lab-in-the-palm-of-your-hand' diagnostic system," said Mr. Campbell. "With our AmpCrystal® platform, which provides an array of diagnostic capabilities at point of interest settings in human and non-human applications as well as improving central laboratory assays, SuperNova is well poised to capture the multi-billion dollar point-of-care and general diagnostic markets."

About SuperNova Diagnostics®, Inc.
SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications. A powerful proprietary nanochemistry, AmpCrystal®, can deliver novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements. SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® Putting the Laboratory in the Palm of Your Hand®. For additional information, please visit www.supernovadiagnostics.com.

Contacts:
Tiberend Strategic Advisors, Inc.
Jason Rando / June Gregg
(212) 827-0020
jrando@tiberend.com / jgregg@tiberend.com

SOURCE SuperNova Diagnostics, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->